<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    OpGen, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About OpGen, Inc.

    OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8071
    • NIN CODE
      ####
    • LEADERSHIP
      Evan Jones
    • FOUNDED
      2002
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc. is an innovative biopharmaceutical company committ...

    Proteostasis Therapeutics, Inc. is an innovativ...

    Filing Type:    PU
    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse p...

    Oncternal Therapeutics is a clinical-stage onco...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Landec Corporation

    Landec Corporation

    Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and...

    Landec Corporation (Nasdaq: LNDC) is a leading ...

    Filing Type:    PU
    Evogene Ltd.

    Evogene Ltd.

    Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel p...

    Evogene (NASDAQ, TASE: EVGN) is a leading biote...

    Filing Type:    PU
    Hologic, Inc.

    Hologic, Inc.

    As the leader women’s health, we deliver life-changing and life-saving diagnosti...

    As the leader women’s health, we deliver life...

    Filing Type:    PU
    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company committing...

    Pieris Pharmaceuticals, Inc. is a, clinical-sta...

    Filing Type:    PU
    Wuxi Biologics (Cayman) Inc

    Wuxi Biologics (Cayman) Inc

    WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...

    WuXi Biologics (stock code: 2269.HK), a Hong Ko...

    Filing Type:    PU
    Novartis AG

    Novartis AG

    Novartis is reimagining medicine to improve and extend people’s lives. As a leadin...

    Novartis is reimagining medicine to improve and...

    Filing Type:    PU
    FRONTEO, Inc.

    FRONTEO, Inc.

    FRONTEO is a leading provider of Artificial Intelligence that analyzes big data an...

    FRONTEO is a leading provider of Artificial Int...

    Filing Type:    PU
    National Research Corporation

    National Research Corporation

    NRC Health is one of the nation’s largest healthcare performance improvement fir...

    NRC Health is one of the nation’s largest hea...

    Filing Type:    PU
    Water Markets LLC

    Water Markets LLC

    Water Markets LLC is here to help everyone embrace the importance of water in a gl...

    Water Markets LLC is here to help everyone embr...

    Amount Raised:    $2,921.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.